Trial Profile
A study investigating the safety, tolerability and pharmacodynamics of bacterial lipase in patients with cystic fibrosis and pancreatic insufficiency Randomized, double-blind, placebo-controlled, single period, parallel group design
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Burlulipase (Primary)
- Indications Cystic fibrosis; Pancreatic disorders
- Focus Adverse reactions
- Sponsors Nordmark Arzneimittel
- 22 Feb 2016 New trial record